Inflammatory Mediators of Acute Kidney Injury in Intensive Care
Key facts
- Who runs it
- Uppsala University
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 1 Jan 2018
- Planned end
- May 2026
- Type of study
- Observational, 3 groups
- Record updated
- 12 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients admitted to the intensive/post operative care unit
- with septic shock or
- post major surgery or
- after intoxication with a chemical compund
Who cannot take part
- Chronic kidney disease or
- Pregnancy or
- Breast feeding or
- intoxication with nephrotoxic compund or
- lack of informed consent
This trial is currently available in Sweden.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Acute kidney injury (AKI) affects more than 50% of patients admitted to the intensive care unit. The most common underlying cause is sepsis. Severe AKI in combination with sepsis is associated with high mortality. The mechanisms for sepsis-induced AKI are largely unknown. Our hypothesis is that the inflammatory response to an infection cause collateral damage to host tissue and contributes to the development of AKI. In this study we want to investigate the presence of novel inflammatory mediators in patients with sepsis, patients subjected to major surgery (sterile inflammation) and non-inflamed patients and correlate their levels with the risk for AKI.
The 3 groups in the trial
- Sepsis
Patients admitted to the intensive care unit with sepsis
- Surgery
Patinets subjected to major surgery and then admitted to the intensive care unit
- Non-inflamed
Otherwise healthy patients admitted to the intensive care unit because of intoxication.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective Studie of Inflammatory Markers in Urine, Plasma and Sputum Associated With Acute Kidney Injury
- Publications
- Bacteriuria and antibiotic use during the third wave of COVID-19 intensive care in Sweden.Infectious diseases (London, England), 2025
- Record updated
- 12 January 2026